Annual Current Liabilities
$3.72 M
+$2.45 M+192.30%
31 December 2023
Summary:
Immix Biopharma annual total current liabilities is currently $3.72 million, with the most recent change of +$2.45 million (+192.30%) on 31 December 2023. During the last 3 years, it has fallen by -$1.55 million (-29.38%). IMMX annual current liabilities is now -29.38% below its all-time high of $5.27 million, reached on 31 December 2020.IMMX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$6.56 M
+$2.66 M+68.24%
30 September 2024
Summary:
Immix Biopharma quarterly total current liabilities is currently $6.56 million, with the most recent change of +$2.66 million (+68.24%) on 30 September 2024. Over the past year, it has increased by +$3.74 million (+132.33%). IMMX quarterly current liabilities is now at all-time high.IMMX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMMX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +192.3% | +132.3% |
| 3 y3 years | -29.4% | +1.6% |
| 5 y5 years | - | - |
IMMX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +1742.5% | at high | +3149.8% |
| 5 y | 5 years | -29.4% | +1742.5% | at high | +3149.8% |
| alltime | all time | -29.4% | +1742.5% | at high | +3149.8% |
Immix Biopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.56 M(+68.2%) |
| June 2024 | - | $3.90 M(-31.0%) |
| Mar 2024 | - | $5.66 M(+52.0%) |
| Dec 2023 | $3.72 M(+192.3%) | $3.72 M(+31.7%) |
| Sept 2023 | - | $2.83 M(+17.9%) |
| June 2023 | - | $2.40 M(+62.7%) |
| Mar 2023 | - | $1.47 M(+15.7%) |
| Dec 2022 | $1.27 M | $1.27 M(+97.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $646.50 K(-33.8%) |
| June 2022 | - | $977.20 K(+167.7%) |
| Mar 2022 | - | $365.10 K(+80.7%) |
| Dec 2021 | $202.00 K(-96.2%) | $202.00 K(-96.9%) |
| Sept 2021 | - | $6.46 M(+7.8%) |
| June 2021 | - | $6.00 M(+13.8%) |
| Dec 2020 | $5.27 M(+14.8%) | $5.27 M |
| Dec 2019 | $4.59 M | - |
FAQ
- What is Immix Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for Immix Biopharma?
- What is Immix Biopharma annual current liabilities year-on-year change?
- What is Immix Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Immix Biopharma?
- What is Immix Biopharma quarterly current liabilities year-on-year change?
What is Immix Biopharma annual total current liabilities?
The current annual current liabilities of IMMX is $3.72 M
What is the all time high annual current liabilities for Immix Biopharma?
Immix Biopharma all-time high annual total current liabilities is $5.27 M
What is Immix Biopharma annual current liabilities year-on-year change?
Over the past year, IMMX annual total current liabilities has changed by +$2.45 M (+192.30%)
What is Immix Biopharma quarterly total current liabilities?
The current quarterly current liabilities of IMMX is $6.56 M
What is the all time high quarterly current liabilities for Immix Biopharma?
Immix Biopharma all-time high quarterly total current liabilities is $6.56 M
What is Immix Biopharma quarterly current liabilities year-on-year change?
Over the past year, IMMX quarterly total current liabilities has changed by +$3.74 M (+132.33%)